Recombinant Herpes Simplex Virus Type 2 Vaccine(Beijing Lvzhu Biological Technology Co Ltd)

重组单纯疱疹病毒2型疫苗（北京绿竹生物技术股份有限公司）

Report date: 2025/11/19 10:01:00

Base Information

Drug NameRecombinant Herpes Simplex Virus Type 2 Vaccine(Beijing Lvzhu Biological Technology Co Ltd)
Drug Alias NameRecombinant HSV-2 Vaccine(Beijing Lvzhu Biological Technology Co Ltd)重组2型单纯疱疹病毒疫苗（北京绿竹生物技术股份有限公司）重组HSV-2疫苗（北京绿竹生物技术股份有限公司）
ClassificationVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes Genitalis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Lvzhu Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Lvzhu Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsHerpes Genitalis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A